ATE274513T1 - Verbindungen und verfahren zur behandlung von schmerz - Google Patents

Verbindungen und verfahren zur behandlung von schmerz

Info

Publication number
ATE274513T1
ATE274513T1 AT00989116T AT00989116T ATE274513T1 AT E274513 T1 ATE274513 T1 AT E274513T1 AT 00989116 T AT00989116 T AT 00989116T AT 00989116 T AT00989116 T AT 00989116T AT E274513 T1 ATE274513 T1 AT E274513T1
Authority
AT
Austria
Prior art keywords
compounds
methods
treating pain
structural diagram
pain
Prior art date
Application number
AT00989116T
Other languages
English (en)
Inventor
Dean Gordon Brown
Wenhua Xiao
Rebecca Ann Urbanek
Megan Murphy
Thomas Michael Bare
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE274513T1 publication Critical patent/ATE274513T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/503—Pyridazines; Hydrogenated pyridazines spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00989116T 1999-12-23 2000-12-19 Verbindungen und verfahren zur behandlung von schmerz ATE274513T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17190699P 1999-12-23 1999-12-23
US23688000P 2000-09-29 2000-09-29
PCT/SE2000/002606 WO2001047923A1 (en) 1999-12-23 2000-12-19 Compounds and methods for the treatment of pain

Publications (1)

Publication Number Publication Date
ATE274513T1 true ATE274513T1 (de) 2004-09-15

Family

ID=26867560

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00989116T ATE274513T1 (de) 1999-12-23 2000-12-19 Verbindungen und verfahren zur behandlung von schmerz

Country Status (6)

Country Link
EP (1) EP1244663B1 (de)
JP (1) JP2003519145A (de)
AT (1) ATE274513T1 (de)
AU (1) AU2566101A (de)
DE (1) DE60013326T2 (de)
WO (1) WO2001047923A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9999944B2 (en) 2012-08-28 2018-06-19 Hobart Brothers Company Systems and methods for welding electrodes
US10112268B2 (en) 2013-10-09 2018-10-30 Hobart Brothers Company Systems and methods for corrosion-resistant welding electrodes

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2263661T3 (es) * 2000-09-29 2006-12-16 Astrazeneca Ab 1,2,5,10-tetrahidropiridazino(4,5-b)quinolin-1,10-dionas y su uso para el tratamiento del dolor.
EP1325004A1 (de) * 2000-09-29 2003-07-09 AstraZeneca AB 1,2,5,10-tetrahydropyridazino[4,5-b]chinolin-1,10-dione und ihre verwendung zur behandlung von schmerzen
EP1325005A1 (de) * 2000-09-29 2003-07-09 AstraZeneca AB 1,2,5,10-tetrahydropyridazino-[4,5-b]chinolin-1,10-dione und ihre anwendung zur behandlung von schmerzen
KR20040068240A (ko) * 2001-12-14 2004-07-30 노보 노르디스크 에이/에스 호르몬 민감성 리파아제의 활성을 감소시키기 위한 화합물및 그들의 사용
WO2004111006A1 (en) * 2003-06-12 2004-12-23 Novo Nordisk A/S Para-subtituted phenyl carbamates as inhibitors of hormone sensitive lipase
SE0403172D0 (sv) * 2004-12-23 2004-12-23 Astrazeneca Ab Manufacturing process
WO2007112015A2 (en) 2006-03-24 2007-10-04 The Feinstein Institute For Medical Research Phenolic hydrazone macrophage migration inhibitory factor inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111266A (en) * 1993-10-22 2002-03-10 Zeneca Ltd 2-HETEROARYL OR 2-ARYLPYRIDAZINO [4,5-b] QUINOLINE - 1, 10 - DIONES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GB9422894D0 (en) * 1994-11-12 1995-01-04 Zeneca Ltd Pyridazino quinoline compounds
GB9507318D0 (en) * 1995-04-07 1995-05-31 Zeneca Ltd Alpha substituted pyridazino quinoline compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9999944B2 (en) 2012-08-28 2018-06-19 Hobart Brothers Company Systems and methods for welding electrodes
US10112268B2 (en) 2013-10-09 2018-10-30 Hobart Brothers Company Systems and methods for corrosion-resistant welding electrodes

Also Published As

Publication number Publication date
EP1244663B1 (de) 2004-08-25
DE60013326T2 (de) 2005-09-08
DE60013326D1 (de) 2004-09-30
EP1244663A1 (de) 2002-10-02
AU2566101A (en) 2001-07-09
JP2003519145A (ja) 2003-06-17
WO2001047923A1 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
ATE334985T1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
ATE299890T1 (de) Inhibitoren von gamma-secretase
MY140488A (en) Substituted oxazolidinones and their use in the field of blood coagulation
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
ATE250576T1 (de) Substituierte pyrrolylverbindungen zur behandlung von entzündungen
ATE248837T1 (de) Chinuclidin-acrylamide
CA2366932A1 (en) Cyclic protein tyrosine kinase inhibitors
DE60121931D1 (de) Chinazolinverbindungen
ATE245152T1 (de) Dioxocyclopentylhydroxamsäure
ATE337316T1 (de) Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
ATE323693T1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
SE0003476D0 (sv) Compounds
ATE274513T1 (de) Verbindungen und verfahren zur behandlung von schmerz
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
AP9801377A0 (en) Tricyclic erythromycin derivatives.
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
DE60030300D1 (de) Topische behandlung zur vorbeugung von augeninfektionen
DE69629282D1 (de) Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern
AP9801235A0 (en) Erythromycin derivatives.
ATE353886T1 (de) Verbindungen und verfahren zur behandlung einer hyperaktiven blase
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties